Gema Hernández — Endo Lab

article 2025

Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study

·doi:10.1016/j.ijgc.2024.100369

article 2025

Hormonal Therapy In Endometriosis And Breast Cancer Risk: A Propensity Score-Matched Real-World Analysis

·doi:10.1016/j.ijgc.2024.101267

article 2025

Real-world assessment of breast cancer risk following hormonal therapy in endometriosis: A Global Collaborative Network propensity score matched analysis.

·doi:10.1200/jco.2025.43.16_suppl.11143

11143 Background: Research suggests endometriosis, an estrogen-dependent condition, may be a potential risk factor for breast cancer (BC) development. While oral contraceptives are the standard treatment, their efficacy is limited in sympto…

article 2024

Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study

iScience ·doi:10.1016/j.isci.2024.109680

Endometriosis is a benign condition characterized by the presence of ectopic endometrial tissue. Our study investigated the effect of endometriosis on the risk of endometrial cancer (EC) and the prognosis of endometriosis-associated EC. In …

article 2023

#434 Association between endometriosis and endometrial cancer: a real world evidence study

·doi:10.1136/ijgc-2023-esgo.55

other 2023

Adenomyosis in Pregnancy-Should It Be Managed in High-Risk Obstetric Units?

Diagnostics ·doi:10.3390/diagnostics13061184

BACKGROUND: Uterine adenomyosis is an increasingly frequent disorder. Our study aimed to demonstrate the presence of obstetric complications in the population affected by this condition to demonstrate the need for follow-up in high-risk obs…